Skip to main content
. 2020 May 14;26(18):2166–2176. doi: 10.3748/wjg.v26.i18.2166

Table 1.

Main virological and biochemical features in the different clinical phases of chronic hepatitis B in HBsAg+ patients

Phase 1: Immune tolerant Phase 2: Immune active Phase 3: Asymptomatic carrier Phase 4: HBV reactivation
HBeAg+ Attempt to remove HBeAg HBeAg- HBeAg+ or -
HBV-DNA ≥ 108 IU/mL HBV-DNA ↓ HBV-DNA < 2000 IU/mL HBV-DNA ↑
Normal LFTs→ no damage Altered LFTs→ damage Normal LFTs→ no damage Altered LFTs→ damage

HBV: Hepatitis B virus; LFT: liver function tests